NHMRC Centre for Blood Transplant and Cell Therapies Webinar 26 August 2022

The Centre for Blood Transplant and Cell Therapies (CBTCT) brings together the largest allogeneic stem cell transplant units in Australia with a focus on identifying transplant and cell therapy strategies to reduce graft versus host disease and improve patient and disease outcomes after transplant. In this webinar series, speakers will review major topics in stem cell transplantation and cell therapy, highlighting how key advances are addressing the current challenges in stem cell transplantation. This webinar features Professor Katy Rezvani who is the Sally Cooper Murray Chair in Cancer Research, Professor of Medicine, Chief of Section for Cellular Therapy, Director of Translational Research and Director of the GMP Facility at the MD Anderson Cancer Centre. Prof Rezvani’s research laboratory focuses on the role of natural killer (NK) cells in mediating immunity against haematologic and solid organ tumours. This research has led to the approval and funding of several investigator-initiated clinical trials of NK cell immunotherapy in patients with hematologic malignancies and solid tumors, as well as the first-in-human clinical trial of off-the-shelf CAR-transduced cord blood NK cells in patients with relapsed/refractory lymphoid malignancies. Prof Rezvani’s work is supported by multiple grants from the National Cancer Institute, the Leukemia and Lymphoma Society, the American Cancer Society, Stand Up to Cancer and the Cancer Prevention & Research Institute of Texas (CPRIT). In this webinar, Prof Rezvani will be outlining the emerging role of NK cell based therapeutics in cancer.

Speaker:

Professor Katy Rezvani – MD Anderson Cancer Centre

When: Friday 26 August 2022, 8am AEST

Link to webinar:

https://uni-sydney.zoom.us/j/83782538124

Link to CBTCT website for all webinar recordings:

https://bloodcelltherapy.org.au/

For full information click here